Therefore, it seems that depending on the conditions and biochemical settings, AMPK (and ultimately metformin) might be a two-edged sword regarding Aβ production and tau protein phosphorylation, and ultimately AD pathology (63). Here, MAPT is linked to Alzheimer disease.